Depression in patients with Parkinson's disease: current understanding of its neurobiology and implications for treatment

S Prange, H Klinger, C Laurencin, T Danaila… - Drugs & Aging, 2022 - Springer
Depression is one of the most frequent and burdensome non-motor symptoms in
Parkinson's disease (PD), across all stages. Even when its severity is mild, PD depression …

SARS‐COV‐2 infection and Parkinson's disease: possible links and perspectives

HM Al‐kuraishy, AI Al‐Gareeb… - Journal of …, 2023 - Wiley Online Library
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the progressive
loss of dopaminergic neurons in the substantia nigra. The hallmarks are the presence of …

The overall impact of COVID‐19 on healthcare during the pandemic: a multidisciplinary point of view

N Sabetkish, A Rahmani - Health Science Reports, 2021 - Wiley Online Library
Abstract Background and Aims The Coronavirus disease 2019 (COVID‐19) pandemic
globally changed the priorities of medical and surgical procedures. It has caused many …

The pathobiological basis of depression in Parkinson disease: challenges and outlooks

KA Jellinger - Journal of neural transmission, 2022 - Springer
Depression, with an estimated prevalence of about 40% is a most common neuropsychiatric
disorder in Parkinson disease (PD), with a negative impact on quality of life, cognitive …

Can SARS-CoV-2 infection lead to neurodegeneration and Parkinson's disease?

L Krey, MK Huber, GU Höglinger, F Wegner - Brain Sciences, 2021 - mdpi.com
The SARS-CoV-2 pandemic has affected the daily life of the worldwide population since
2020. Links between the newly discovered viral infection and the pathogenesis of …

Caregiver burden in Parkinson disease: a scoping review of the literature from 2017-2022

WW Aamodt, BM Kluger, M Mirham… - Journal of Geriatric …, 2024 - journals.sagepub.com
Caregiver burden is a term that refers to the adverse effect of caregiving on the physical,
emotional, social, spiritual, and financial well-being of the caregiver. Caregiver burden is …

Access to device-aided therapies in advanced Parkinson's disease: navigating clinician biases, patient preference, and prognostic uncertainty

M Auffret, D Weiss, F Stocchi, M Vérin… - Journal of Neural …, 2023 - Springer
Abstract Device-aided therapies (DAT), which include deep brain stimulation and pump-
based continuous dopaminergic stimulation with either levodopa or apomorphine, are …

Feasibility, safety, and effectiveness of telerehabilitation in mild-to-moderate Parkinson's disease

E Bianchini, C Onelli, C Morabito, M Alborghetti… - Frontiers in …, 2022 - frontiersin.org
Introduction Parkinson's disease (PD) patients frequently engage in rehabilitation to
ameliorate symptoms. During the Coronavirus disease 2019 (COVID-19) pandemic, access …

SARS-CoV-2 and Parkinson's Disease: A Review of Where We Are Now

I Boura, MA Qamar, F Daddoveri, V Leta… - Biomedicines, 2023 - mdpi.com
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), which causes coronavirus
disease 2019 (COVID-19), has been discussed in the context of Parkinson's disease (PD) …

Psychological outcomes of the COVID-19 pandemic in patients with Parkinson's disease: A systematic review

F Nabizadeh, Z Seyedalhosseini… - Journal of Clinical …, 2022 - Elsevier
Background There were concerns about the psychological outcomes of coronavirus disease
from the beginning of the pandemic. Parkinson's disease (PD) patients seem to be more …